Pioneering company eliminates adoption barriers to navigated and robotic joint replacement through new radar surgical tracking technology and small footprint, cost-effective surgical solutions
NEW YORK, Jan. 04, 2022 (GLOBE NEWSWIRE) — Caira Surgical announced its latest influx of $5M seed capital in an oversubscribed series seed financing that closed last month. Caira’s investor syndicate includes smart-money venture and strategic MedTech investors.
Caira’s proprietary technology seeks to revolutionize the usability, safety, and accessibility of advanced surgical navigation and robotics for orthopedic surgery. The company’s first product is a breakthrough sub-millimeter-accurate radar tracking system for knee replacement surgery. The system leverages advanced radar technologies to overcome line-of-sight interference and eliminate invasive surgical hardware and high-cost, large footprint capital equipment inherent with incumbent surgical tracking systems.
“We’re thrilled to achieve this funding milestone in partnership with our industry-savvy investors,” said Jon Greenwald, Co-Founder & CEO of Caira Surgical. The strategic Medtech leader of more than 20 years explained, “the series seed funding enables Caira to continue developing our breakthrough technology and positively impact orthopedic surgery and patient welfare. Additionally, the composition, commitment, and enthusiasm of our investor syndicate ensure that Caira will have continued access to the funding and resources necessary to realize our technology vision and meet our commercial objectives.”